DK3157522T3 - Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste - Google Patents
Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste Download PDFInfo
- Publication number
- DK3157522T3 DK3157522T3 DK15728025T DK15728025T DK3157522T3 DK 3157522 T3 DK3157522 T3 DK 3157522T3 DK 15728025 T DK15728025 T DK 15728025T DK 15728025 T DK15728025 T DK 15728025T DK 3157522 T3 DK3157522 T3 DK 3157522T3
- Authority
- DK
- Denmark
- Prior art keywords
- combinations
- treatment
- horse
- diseases
- muscarin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2250/00—Specially adapted for animals
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14172925 | 2014-06-18 | ||
| PCT/EP2015/063265 WO2015193213A1 (en) | 2014-06-18 | 2015-06-15 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3157522T3 true DK3157522T3 (da) | 2019-12-09 |
Family
ID=50972546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15728025T DK3157522T3 (da) | 2014-06-18 | 2015-06-15 | Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US9474747B2 (da) |
| EP (2) | EP3157522B1 (da) |
| KR (1) | KR102618119B1 (da) |
| AU (2) | AU2015276310B2 (da) |
| CA (1) | CA2952701C (da) |
| CY (1) | CY1122335T1 (da) |
| DK (1) | DK3157522T3 (da) |
| ES (1) | ES2759247T3 (da) |
| HR (1) | HRP20192010T1 (da) |
| HU (1) | HUE051527T2 (da) |
| LT (1) | LT3157522T (da) |
| MX (2) | MX370430B (da) |
| PL (1) | PL3157522T3 (da) |
| PT (1) | PT3157522T (da) |
| RS (1) | RS59613B1 (da) |
| SI (1) | SI3157522T1 (da) |
| WO (1) | WO2015193213A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2888428C (en) | 2012-12-21 | 2021-07-13 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
| DK2934544T3 (da) | 2012-12-21 | 2019-03-04 | Boehringer Ingelheim Vetmedica Gmbh | Farmaceutisk formulering omfattende ciclesonid |
| ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
| CN111840256A (zh) * | 2019-04-29 | 2020-10-30 | 上海谷森医药有限公司 | 一种雾化吸入剂及其制备方法 |
| CN112752572B (zh) * | 2019-05-23 | 2022-02-22 | 广州谷森制药有限公司 | 含有三苯乙酸维兰特罗和芜地溴铵的可吸入溶液组合物 |
| WO2021262648A1 (en) * | 2020-06-23 | 2021-12-30 | Anovent Pharmaceutical (U.S.), Llc | Preparation of a pharmaceutical composition of olodaterol and budesonide |
| CA3186956A1 (en) | 2020-07-31 | 2022-02-03 | Chemo Research , S.L. | Combination therapy for inhalation administration |
| EP4221707A1 (en) | 2020-09-29 | 2023-08-09 | Aerorx Therapeutics LLC | Liquid formulations of indacaterol |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5954049A (en) | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| US5823179A (en) * | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
| US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
| DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US6904908B2 (en) * | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
| DE10237739A1 (de) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
| US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| US20040053902A1 (en) * | 2002-09-13 | 2004-03-18 | Smith C. Steven | Novel composition and method for treatment of upper respiratory conditions |
| US20060293293A1 (en) | 2003-05-22 | 2006-12-28 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
| US20050020692A1 (en) * | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
| ES2452691T5 (es) | 2003-09-16 | 2022-09-14 | Covis Pharma Gmbh | Uso de ciclesonida para el tratamiento de enfermedades respiratorias |
| PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
| JP2007533706A (ja) | 2004-04-20 | 2007-11-22 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用 |
| JP2008504341A (ja) | 2004-06-29 | 2008-02-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ステロイドと抗コリン作用剤とを含む吸入用薬剤 |
| DE102004056579A1 (de) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
| US20070028923A1 (en) | 2005-08-08 | 2007-02-08 | Patrick Souris | Tip-laryngeal airway |
| UY30543A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
| UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
| PL2346625T5 (pl) | 2008-10-30 | 2024-04-29 | Primetals Technologies Germany Gmbh | Sposób nastawiania grubości wylotowej materiału walcowanego przebiegającego przez wieloklatkowy zespół walcowniczy, urządzenie sterujące i/lub regulujące oraz instalacja walcownicza |
| US8815258B2 (en) * | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| WO2010149280A1 (en) * | 2009-06-25 | 2010-12-29 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
| US20150202297A1 (en) * | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
| US20150202148A1 (en) * | 2012-07-05 | 2015-07-23 | Arven llac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
| WO2014016548A2 (en) * | 2012-07-27 | 2014-01-30 | Cipla Limited | Pharmaceutical composition |
| US9539408B2 (en) * | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
| DK2934544T3 (da) * | 2012-12-21 | 2019-03-04 | Boehringer Ingelheim Vetmedica Gmbh | Farmaceutisk formulering omfattende ciclesonid |
| CA2888428C (en) | 2012-12-21 | 2021-07-13 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
| RS60034B1 (sr) * | 2013-08-20 | 2020-04-30 | Boehringer Ingelheim Vetmedica Gmbh | Inhalator |
| PT3035886T (pt) * | 2013-08-20 | 2021-01-04 | Boehringer Ingelheim Vetmedica Gmbh | Nalador |
| ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
-
2015
- 2015-06-15 ES ES15728025T patent/ES2759247T3/es active Active
- 2015-06-15 CA CA2952701A patent/CA2952701C/en active Active
- 2015-06-15 AU AU2015276310A patent/AU2015276310B2/en active Active
- 2015-06-15 WO PCT/EP2015/063265 patent/WO2015193213A1/en active Application Filing
- 2015-06-15 KR KR1020177001472A patent/KR102618119B1/ko active IP Right Grant
- 2015-06-15 EP EP15728025.6A patent/EP3157522B1/en active Active
- 2015-06-15 SI SI201531016T patent/SI3157522T1/sl unknown
- 2015-06-15 PT PT157280256T patent/PT3157522T/pt unknown
- 2015-06-15 EP EP19192103.0A patent/EP3603640A1/en active Pending
- 2015-06-15 MX MX2016016720A patent/MX370430B/es active IP Right Grant
- 2015-06-15 HU HUE15728025A patent/HUE051527T2/hu unknown
- 2015-06-15 PL PL15728025T patent/PL3157522T3/pl unknown
- 2015-06-15 RS RS20191483A patent/RS59613B1/sr unknown
- 2015-06-15 DK DK15728025T patent/DK3157522T3/da active
- 2015-06-15 LT LT15728025T patent/LT3157522T/lt unknown
- 2015-06-16 US US14/740,582 patent/US9474747B2/en active Active
-
2016
- 2016-09-23 US US15/274,259 patent/US10342789B2/en active Active
- 2016-12-15 MX MX2019014935A patent/MX2019014935A/es unknown
-
2019
- 2019-05-08 US US16/406,918 patent/US10682345B2/en active Active
- 2019-11-06 HR HRP20192010TT patent/HRP20192010T1/hr unknown
- 2019-12-02 CY CY20191101258T patent/CY1122335T1/el unknown
-
2020
- 2020-04-06 AU AU2020202402A patent/AU2020202402B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3157522B1 (en) | 2019-09-04 |
| PT3157522T (pt) | 2019-12-13 |
| AU2020202402B2 (en) | 2021-05-27 |
| LT3157522T (lt) | 2019-11-25 |
| HUE051527T2 (hu) | 2021-03-01 |
| KR102618119B1 (ko) | 2023-12-27 |
| CA2952701C (en) | 2023-09-19 |
| AU2015276310A1 (en) | 2016-12-08 |
| US9474747B2 (en) | 2016-10-25 |
| AU2015276310B2 (en) | 2020-01-16 |
| ES2759247T3 (es) | 2020-05-08 |
| EP3157522A1 (en) | 2017-04-26 |
| PL3157522T3 (pl) | 2020-03-31 |
| US10682345B2 (en) | 2020-06-16 |
| WO2015193213A1 (en) | 2015-12-23 |
| HRP20192010T1 (hr) | 2020-02-07 |
| SI3157522T1 (sl) | 2020-01-31 |
| US20190262329A1 (en) | 2019-08-29 |
| US20150366855A1 (en) | 2015-12-24 |
| RS59613B1 (sr) | 2020-01-31 |
| EP3603640A1 (en) | 2020-02-05 |
| US10342789B2 (en) | 2019-07-09 |
| CA2952701A1 (en) | 2015-12-23 |
| MX2016016720A (es) | 2017-04-13 |
| MX370430B (es) | 2019-12-13 |
| MX2019014935A (es) | 2020-02-13 |
| US20170007593A1 (en) | 2017-01-12 |
| AU2020202402A1 (en) | 2020-04-30 |
| CY1122335T1 (el) | 2021-01-27 |
| KR20170016986A (ko) | 2017-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3347030T3 (da) | Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3227262T3 (da) | Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3212255T3 (da) | Selvorienterende sprøjte og sprøjtegrænseflade | |
| DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
| DK3102189T3 (da) | Sammensætning og fremgangsmåde til at fremme søvn | |
| DK3157522T3 (da) | Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste | |
| DK3183010T3 (da) | Anordning og tilhørende fremgangsmåde til behandling af medicinsk affald | |
| DK3103715T3 (da) | Styreindretning og styringsfremgangsmåde dertil | |
| DK3157534T3 (da) | Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande | |
| DK3265087T3 (da) | Fremgangsmåde til behandling med tradipitant |